Sort   by:  
 Page size 
UnknownPersistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Not available
S-EPMC9281359 | biostudies-literature
UnknownCoverage of iron and folic acid supplementation in India: progress under the Anemia Mukt Bharat strategy 2017-20.
Not available
S-EPMC9113188 | biostudies-literature
UnknownHumoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.
Not available
S-EPMC11497953 | biostudies-literature
UnknownSafety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
Not available
S-EPMC7825810 | biostudies-literature
UnknownSafety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.
Not available
S-EPMC8221739 | biostudies-literature
UnknownProtective efficacy of COVAXIN® against Delta and Omicron variants in hamster model.
Not available
S-EPMC9493142 | biostudies-literature
UnknownImmunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model.
Not available
S-EPMC7829205 | biostudies-literature
UnknownTh1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation.
Not available
S-EPMC7944858 | biostudies-literature
UnknownImmunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques.
Not available
S-EPMC7925524 | biostudies-literature
UnknownEfficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
Not available
S-EPMC8584828 | biostudies-literature
Sort   by:  
 Page size